NDAORALTABLET
Approved
Jan 1958
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
20
Data completeness
2/8 — Basic
Drug data last refreshed 4h ago · AI intelligence enriched 3d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
KENACORT (triamcinolone) is an oral corticosteroid tablet approved in 1958 for systemic inflammatory and autoimmune conditions. It works by suppressing immune response and reducing inflammation across multiple organ systems. The drug is used for conditions including rheumatoid arthritis, allergic reactions, and various dermatologic and endocrine disorders.
LOE Approaching
As an older established product approaching loss of exclusivity with moderate competitive pressure (30%), commercial teams are likely focused on defending market share through physician relationships rather than growth initiatives.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (20)
Efficacy of Clobetasol Vs Intralesional Triamcinolone in Lichen Planus Treatment
Started Oct 2026
50 enrolled
Hypertrophic Lichen Planus
Triamcinolone Ketorolac (TriKe) Knee Trial
Started Sep 2022
150 enrolled
Osteoarthritis, Knee
Triamcinolone Packing Following Endoscopic Sinus Surgery
Started Jan 2021
22 enrolled
Sinusitis
Drug-Drug Interaction Study of Lorecivivint and Triamcinolone Acetonide in Healthy Volunteers
Started Oct 2020
40 enrolled
Drug-Drug Interaction
Study of Cingal® and Triamcinolone Hexacetonide for the Relief of Knee Osteoarthritis Pain
Started Sep 2020
231 enrolled
Osteoarthritis, Knee
Worked on KENACORT at Teva? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.